Navigation Links
New England Cord Blood Bank: Umbilical Cord Tissue Banking
Date:3/28/2011

BOSTON, March 28, 2011 /PRNewswire/ -- For over 15 years now, parents have had the option to save the blood that is found within their baby's umbilical cord immediately following birth. The blood is rich in hematopoietic stem cells (HSC's). These multipotent stem cells have the ability to give rise to all blood cell types. Parents have the peace of mind of knowing that their child, and perhaps siblings and other family members, could in fact use these cells as part of a curative treatment for well over 80 blood borne illnesses. This process, commonly referred to as cord blood banking, has allowed for more than 6,000 transplants of these stem cells for patients who will benefit from the repopulation of their blood supply.

Now, with medical advances continuing in the second decade of this practice, scientists and doctors have begun to realize the value in the very tissue that makes up the umbilical cord itself. The cord, no longer seen as just a vessel for these precious cells, is actually comprised of yet another stem cell type. The tissue is comprised of mesenchymal stem cells (MSC's). These "super cells" have the primitive beginnings of every major tissue type in the human body. Therefore, it is now believed that the harvesting and cryopreservation of these cells may likely lead to treatment and potentially cures for a wide array of diseases and injuries. These regenerative cells will be key players in medical advances in the areas of cardiac, neuronal, bone, cartilage, and adipose tissue repair. Researchers studying conditions such as Parkinson's Disease, Alzheimer's Disease, Type 1 Diabetes, spinal cord injury and cardiac damage have long known the potential for stem cells in the future treatments and cures. Now, in one easy harvesting opportunity, new parents have the chance to bank both cell types for their family's future health.

The family simply makes this decision in advance of the birth and contracts with a cryogenic laboratory to p
'/>"/>

SOURCE New England Cord Blood Bank
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Stryker Knee and Hip Implants Demonstrate Lowest Revision Rates, According to the National Joint Registry for England and Wales
2. New England Biolabs Introduces OneTaq™ DNA Polymerase, a Robust Solution for Routine and Difficult PCR
3. The New England Journal of Medicine Publishes Results of Fidaxomicin Phase 3 Trial Showing Significantly Lower Recurrence Rates and Improved Global Cure Rates Compared to Vancomycin in Patients with Clostridium difficile Infection (CDI)
4. New England Biolabs Develops Novel Small RNA NGS Protocol: Reagents Improve Yield and Decrease Adaptor-Dimer Formation
5. CSL Behring Awards Advocacy Grants to Patient Groups in Maryland, New England, the Midwest and Washington
6. Canadas Michael Smith Genome Sciences Center Validates NEBNext™ DNA Sample Preparation Reagents From New England Biolabs for Use in Next Generation Sequencing
7. New England Journal of Medicine Publishes Data from Pivotal Phase 3 PROVENGE IMPACT Study
8. New England Biolabs Launches NEBNext(TM) DNA Sample Prep Master Mix Set 3 for Use with SOLiD(TM) 3
9. Wellcome Trust Sanger Institute to use NEBNext(TM) DNA Sample Preparation Reagents from New England Biolabs for Next Generation Sequencing
10. Organogenesis CEO Geoff MacKay and COO / CFO Gary Gillheeney Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Winners in New England
11. Ontario Institute for Cancer Research Validates NEBNext(TM) DNA Sample Preparation Reagents from New England Biolabs for use in Next Generation Sequencing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , July 10, 2014 /PRNewswire-iReach/ -- Tute ... interpretation, today announced an agreement with Lineagen, ... for Lineagen,s NextStep Dx PLUS.  Lineagen, ... and neurological disorders, currently offers FirstStep Dx ... testing service used by healthcare providers as ...
(Date:7/10/2014)... THOUSAND OAKS, Calif., July 10, 2014   Ceres, ... biotechnology and seed company, announced today financial results for ... an update on its business. Ceres reported ... progress in product performance this growing season in Brazil, ... that affected the company,s sorghum evaluation areas for part ...
(Date:7/10/2014)... may help in the fight against terrorism with the ... of explosives with the use of light and special ... and Actuators B: Chemical , the researchers describe a ... concentrations as low as 6.3 ppm (parts per million). ... minutes. , "Traditionally explosives detection has involved looking for ...
(Date:7/10/2014)... A new study published today in the journal ... has found that time of day and sleep deprivation ... could be crucial when looking at the best time ... and heart disease, and for administering medicines effectively. , ... of Cancer Research, London, investigated the links between sleep ...
Breaking Biology Technology:Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 3Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 4Ceres Announces Fiscal Third Quarter 2014 Financial Results 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 3Ceres Announces Fiscal Third Quarter 2014 Financial Results 4Ceres Announces Fiscal Third Quarter 2014 Financial Results 5Ceres Announces Fiscal Third Quarter 2014 Financial Results 6Ceres Announces Fiscal Third Quarter 2014 Financial Results 7Ceres Announces Fiscal Third Quarter 2014 Financial Results 8Ceres Announces Fiscal Third Quarter 2014 Financial Results 9Detecting trace amounts of explosives with light 2Time of day crucial to accurately test for diseases, new research finds 2
... CRANBURY, N.J., March 11 Amicus Therapeutics (Nasdaq: ... and Chief Executive Officer John F. Crowley will be ... Healthcare Conference. Mr. Crowley,s presentation is scheduled to ... Time.Individuals can listen to a live webcast of the ...
... CITY, March 11 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ... on endocrinology and oncology, today reported financial and operating results for ... 2008 Highlights, - February, ... a Phase 2 trial in advanced, ...
... Wednesday, March 11, 2009 at 4:30 p.m. Eastern TimeBOTHELL, ... Inc. ("OncoGenex" or the "Company") (NASDAQ: OGXI ... 2008 financial results, reviewed the Company,s highlights and provided ... active year from an execution standpoint as we took ...
Cached Biology Technology:AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 2AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 3AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 4AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 5AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 6AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 7AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 8AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 9AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 10OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 2OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 3OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 4OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 5OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 6OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 7OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 8OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 9OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 10OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 11OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 12
(Date:7/10/2014)... of overfishing in the English Channel has resulted in ... and left fishermen ,scraping the barrel, for increasing amounts ... cod, haddock and many other species at the head ... many removed from the area completely., These are some ... biologists at Plymouth University, in association with international non-profit ...
(Date:7/10/2014)... even if you are a big, bad sea scorpion. ... shallow waters for any prey in sight. The next, ... scientists, you,re reduced to trolling for weaker, soft-bodied animals ... lot of the giant pterygotid eurypterid, the largest arthropod ... published in the journal Biology Letters , dramatically ...
(Date:7/10/2014)... Endomedix, a start-up company housed at NJIT,s business incubator, ... spray-on gel that surgeons will use to staunch bleeding ... onto a surgical site, and the natural bio-polymer solutions ... the patient within 30 seconds. , The gel ... It will translate into less time for the patient,s ...
Breaking Biology News(10 mins):Overfishing in the English Channel leaves fisherman scraping the bottom of the barrel 2Overfishing in the English Channel leaves fisherman scraping the bottom of the barrel 3Extinct sea scorpion gets a Yale eye exam, with surprising results 2A start-up at NJIT develops bleeding-control gel for brain surgery 2
... effect of cocaine on mice by genetically manipulating a ... , While the researchers aren't suggesting that these genetic ... light the key protein that controls cocaine's effects in ... achieve the same results and therefore help addicts overcome ...
... plant species are not only more productive, they are ... extremes, pests and disease over long periods of time. ... of Nature, are the culmination of 12 years of ... at the University of Minnesota, to explore the value ...
... the genes in the fruitfly genome, Johns Hopkins scientists have ... and simultaneously captured a global view of all the genes ... The study, to be published April 3 in Developmental Cell, ... cells that move similarly to spread beyond an original tumor, ...
Cached Biology News:Genetically altered mice no longer like cocaine 2Genetically altered mice no longer like cocaine 3Biodiversity key to sustainable biofuel according to University of Minn. researcher's findings 2Researchers identify genes in fruitflies that may shed light on human cancer spread 2
Chicken polyclonal to YebU ( Abpromise for all tested applications). Antigen: Full length YebU (Escherichia coli)...
Request Info...
Human Cell Line Slides...
... Detection System combines the indirect labeling ... and Signets unique formulation of ultra ... reliablility. Signet reagents will achieve excellent ... automated protocols. ,Signets USA Detection reagents ...
Biology Products: